PMS2 pathogenic variants underlie a distinct subset of LS-associated ECs that can be masked by MLH1 hypermethylation due to the current LS screening approach that associates the simultaneous loss of MLH1 and PMS2 with MLH1-d and reflex testing for MLH1-PHM [30]. This evidence concerns the gene PMS2 and Leigh syndrome.